My other question has to do with patent extension. Let's say there's a three-year patent extension. Could you comment on how that would affect the generic drug companies in Canada?
We know that generic drug costs are higher in Canada than in many countries in the world, but we have a very robust generic industry in Canada. If it were simply a matter of delay, where their business plan would change in the short term but not in the long term, because it would only be a delay of three years, they'd still be in business. I don't see any reason why that would close the industry down.
Do you want to comment on that? Have you really looked at what that would do? It's extremely important for Alzheimer's disease as well that we have access to plentiful and quality cheaper drugs.